Comparison of oral and intraperitoneal iron supplementation in anaemic
rats: a re-evaluation of the mucosal block theory of iron absorption* To evaluate the extent to which daily oral Fe supplements may block Fe absorption from a subsequent dose, we compared effects of oral and intraperitoneal (i.p.) Fe supplementation on Fe status in anaemic rats (haemoglobin (Hb) 90 g/l). A ligated duodenal loop technique was used to assess the effects of the Fe supplements administered either orally or i.p. at different frequencies on Fe absorption from a subsequent test dose. Anaemic Sprague-Dawley rats were assigned to seven groups of eight rats each and received either oral or i.p. Fe supplements for 3 d as follows:
(1) 4 mg oral supplement daily (three doses in 3 d); (2) 4 mg oral supplement once (one dose on day 1,low-Fe dose ondays 2 and 3); (3) 12mg oral supplement once (one dose on day 1,low-Fe dose ondays 2 and 3); (4) 3.2mg i.p. supplement daily (three doses in 3d); (5) 3.2mg i.p. supplement once (one dose on day 1); (6) 9.6 mg i.p. supplement once (one dose on day 1); (7) low-Fe diet (control). The effectiveness of the supplements in treating Fe deficiency on each of the two test-factors, i.e. route of administration and frequency of dose, was assessed by determining Hb-Fe gain and liver-Fe stores after the 3 d test period. Oral supplementation was as effective as i.p. in improving the Fe status of the anaemic animals. However, a 15min absorption of a radio-Fe test dose from a ligated loop in i.p.-supplemented groups was significantly higher (11.68 (SD 1.70) %, 17.49 (SD 4.59) %, 16.71 (SD 3.39) %) than in orally supplemented groups (3.24 (SD 1.35) %, 2.45 (SD 1.05) %, 1.80 (SD 0.35) %) despite equal body Fe stores. No significant difference in intestinal Fe absorption efficiency was detected within the oral groups but those supplemented only once were more effective than or as effective as the group receiving daily supplements for 3 d in improving Fe status as indicated by Hbregeneration efficiency. We conclude that there is a mucosal block with the administration of oral Fe supplements but the extent of this blocking effect during oral Fe supplementation is not as dramatic as currently thought in the context of the poor efficacy of daily Fe supplementation programmes.
Iron: Anaemia: Intestine: Mucosal block
Many studies using a single dose of Fe have provided evidence of diminished Fe absorption after the consumption of a large Fe dose (Hahn et al. 1943; Brown et al. 1958; Solomons et al. 1983; O'Neil-Cutting & Crosby, 1987) . Brown et al. (1958) found that a large dose, i.e. 2-4mg of Fe/kg body weight, resulted in decreased absorption of the subsequent radio-Fe tracer. This effect lasted about 6 h in Fe-replete subjects and up to 3 h in Similarly, the mechanism behind the blocking effect is unknown. On the one hand, intestinal mucosal Fe concentration is believed to play a role in Fe absorption (Conrad & Crosby, 1963) . It is assumed that the blocking effect during daily Fe supplementation occurs as a consequence of the loading of the cells with Fe from the previous supplemental dose, which in turn causes a lower absorption of the next dose. On the other hand, Fe absorption is affected by body Fe stores. Rebuilding storage Fe during the treatment of Fe deficiency is a slow process because Fe absorption is inversely proportional to Fe status. Norrby & Solve11 (1974) found that Fe absorption from supplemental Fe in Fe-deficient patients was directly related to the degree of Fe deficiency; Fe absorption in three successive 1Od periods was shown to decrease as Fe repletion occurred.
According to Crosby's (1963) hypothesis, in states of Fe deficiency when little storage Fe exists in the body, the transport of Fe from the gastrointestinal tract through the mucosal cells into the body would be fast and efficient. However, data from recent studies showing that intermittent Fe supplementation is more efficient than or as efficient as daily supplementation (Schultink et al. 1995; Viteri et al. 1995; Viteri, 1996) suggest that there is a pronounced blocking effect even in anaemic individuals with the administration of daily Fe supplements.
In view of the many trials now underway in developing countries to test the efficacy of change from daily to weekly Fe supplementation, we conducted this study to understand better the blocking effect in the context of Fe deficiency and supplementation therapy. The purpose of this study was two-fold: (1) to re-evaluate the concept of the blocking effect in the context of Fe deficiency and supplementation therapy, and (2) to examine whether the blocking effect is indeed explained by Fe levels in the mucosal cells independent of body Fe stores. Specifically, we studied the effect of a 3 d Fe supplementation period, both orally and intraperitoneally (i.p.), on Fe absorption from a subsequent test dose.
Materials and methods

Animals and diets
Fifty-six Sprague-Dawley male weanling rats (Camm Research Lab Animals, Wayne, NJ, USA) were individually housed in stainless steel cages with mesh bottoms in a temperature-controlled room (20-22") on a 12 h dark-light cycle. Animal care procedures and experimental protocols were approved by the Cornell University Institutional Animal Care and Use Committee.
The rats initially weighed about 70g each and had free access to a low-Fe diet for the first 4d. They were then trained to meal-feed as described previously (Benito et al. 1997) . Two meals were offered daily: one at 06.00 and one at 18.00 hours. Development of anaemia was monitored by measuring haemoglobin (Hb) concentrations in six randomly selected animals. Blood samples were collected as described previously (Benito et al. 1997) . Mild anaemia (90g Hb/l) became apparent after the rats were fed on the low-Fe diet for 12 d. Subsequently, Hb concentrations were determined in all animals and the rats were assigned to treatment groups.
After the groups were formed, animals in oral groups received 1.0 g of premeal before the morning meal at 06.00 hours. The premeal consisted of low-Fe diet and sucrose (50 : 50, w/w) to which the Fe supplement was added. Rats in i.p. groups received Fe injections before a premeal that consisted of the low-Fe diet and sucrose only. The groups given one dose in 3 d received the Fe-deficient diet on the 2 d after administration of the Fe supplement.
A low-Fe diet was purchased (ICN Biomedicals Inc., Cleveland, OH, USA). It was manufactured according to the specifications of the AIN-76 diet (Bieri et al. 1977; Bieri, 1980) but without ferric citrate. By analysis, the diet contained 7.9 (SD 0.5, n 3) mg Fe/kg diet. 
Supplements and 59Fe test dose
Experimental design
Supplemental Fe was administered either orally or i.p. to Fe-depleted (90g Hb/l) rats. The rats received the Fe supplement either once or three times on three consecutive days. Rats were allotted by Hb concentration to groups of eight rats each. Each group was then assigned randomly to one of seven treatments (Table 1 ). The i.p. Fe doses contained 80 % of the amount of Fe in the oral doses in order to adjust for efficiency of intestinal absorption of Fe. Each treatment group consisted of eight animals. Terminal surgery was conducted on fourteen rats on each of four successive days. Each surgical group consisted of two animals from each of the seven treatment groups. Rats in the surgical groups were selected on the basis of body weight so that the largest, i.e. heaviest, animals were chosen for surgery first. This arrangement allowed smaller animals extra time to grow so that their body weights on their respective surgerydays would be roughly equal to those who preceded them. The order in which animals were selected for surgery on each day was randomized and the supplementation for each batch was staggered to synchronize with the surgery schedule.
Ligated duodenal segment procedure (surgery)
Animals were anaesthetized with a 2 : 1 (v/v) mixture of ketamine hydrochloride (KetasetB, Henry Schein Inc., Port Washington, NY, USA) and xylazine (Rompun@, Henry Schein Inc., Port Washington, NY, USA). The abdomen was opened by a 30-40 mm midline incision and a 100 mm segment of the small intestine was ligated. A ligature (Ligapak 3-0, Ethicon Inc., Somerville, NJ, USA) was loosely tied around the small intestine at the pyloric valve. A second ligature was firmly tied approximately 100mm posterior to the first. A needle (25G, 160mm (0.625in)) was inserted into the lumen of the duodenal segment under the loosely tied ligature which was then tightened before the injection of 0.5 ml of the Fe test dose. After the injection, the needle was withdrawn, the incision was closed and covered with saline-soaked cotton gauze, and the rat was kept warm under the heat of a lamp. After 15min, the anaesthetized animal was assayed in a whole-bod gamma-scintillation spectrometer to determine the initial Fe activity. Then the animal was killed by C02 overexposure, the duodenal se ment immediately removed, and the carcass assayed for '9Fe activity. The duodenal segment was placed on a chilled glass plate after removal of adherent tissue. The tied duodenal segment was cut open by snipping off the ends of the segment close to the ligature and the lumen contents were flushed into a vial with a syringe containing 12 ml ice-cold Ca-and Mg-free Hanks' balanced salt solution buffered with 0-005 ~-Tris-HCl at pH 7.4 (Life Technologies Inc., GIBCO, Grand Island, NY, USA).
Fe absorption was determined by expressin the 59Fe in the carcass as a percentage of the initial 5' Fe activity.
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Blood samples were collected by heart-puncture phlebotomy for final Hb determinations. Livers were removed and placed in counting vials.
Preparation of mucosal cells and ferritin determination
Isolation of mucosal cells from the segment was done by mechanical vibration (Momtazi & Herbert, 1973; Savin & Cook, 1978; Whittaker et al. 1989) as described previously (Benito et al. 1997) . Mucosal cell ferritin was measured by an immunoassay kit (Spectro Rat Ferritin, Ramco Laboratories, Houston, TX, USA). Protein concentration in the epithelial cell suspension was measured with a protein assay kit using serum albumin as a standard (Bio-Rad Laboratories, Life Science Group, Richmond, CA, USA).
Iron status parameters
Liver non-haem Fe was measured by the method of Torrance & Bothwell (1968) and Hb concentrations were determined by the cyanomethaemoglobin method (National Committee for Clinical Laboratory Standards, 1984).
59Fe analyses
Carcasses were assayed for 59Fe in a small animal wholebody gamma-scintillation spectrometer as described by Welch & House (1980) . Luminal contents, rinsings, and other samples were analysed for 59Fe in an automatic gamma-counter (Auto-Gamma model 5530, Packard Instruments, Downers Grove, IL, USA). A ropriate standards and blanks were prepared. The '!e data were corrected for isotopic decay and differences in the counting efficiency of the two counters.
Statistical analyses
Data are reported as means with standard errors. They were analysed according to randomized block design for twoway ANOVA using Minitab (Statistical Software Release 10, Minitab Inc., State College, PA, USA). Following a significant F test (P<O.O5), Tukey's test was used to determine significant differences between means (Snedecor & Cochran, 1989) . 
Results
Effect of supplementation on body iron status and growth (Fig. 1) .
Hb regeneration efficiency (HRE; Hb gain/Fe intake) averaged 16 (4mg daily), 30 (4mg once), and 19 (12mg once) % for the oral groups, and 23 (3-2mg daily), 28 (3.2 mg once), and 23 (9.6 mg once) % for the i.p. groups. It should be noted that HRE of the group receiving a single oral dose (4mg) was remarkably higher than that of three daily oral doses of 4mg (30 v. 16%) and that although a greater proportion of Fe is generally absorbed with a smaller dose (Hahn et al. 1951) , we observed in the oral groups, that a single dose of 12mg was as effective in improving the Fe status of the animals as three daily doses of 4mg each (Table 2) .
Fe repletion, in terms of liver non-haem Fe, followed a similar pattern. Hb-Fe gain was significantly correlated with liver Fe values ( r 0.724, P < 0.001).
ESfect of supplementation on absorption eficiency via ligated loops
Since Fe absorption is affected by many factors including quantity of dose (Hahn et al. 1951) , we also evaluated the efficiency of mucosal cells to absorb Fe after exposing them to supplemental Fe via either the oral or i.p. route. Thus, we use 'absorption efficiency' to mean mucosal cell Fe absorption efficiency independent of dose quantity.
We encountered some problems involving anaesthesia during the ligated-loop procedure. A few animals died from anaesthetic overdose. Since all missing observations came from the first 2 d (surgical groups 1 and 2), the data presented here only correspond to four animals per treatment group, i.e. two rats per surgery on each of the last 2 d. Table 3 shows the distribution of 59Fe from the test dose after a 15min absorption period. Data are expressed as percentages of the total amount of isotope administered to the animal. The length of the ligated duodenal segment was similar for all animals with an average of 90mm.
Fe absorption was greater in groups supplemented by i.p. injection than in groups supplemented orally. The control group differed significantly from groups receiving oral supplements but not from i.p. groups. No significant difference in absorption efficiency was detected within the oral or i.p. groups.
Effect of supplementation regimens on duodenal mucosal ferritin Table 4 shows femtin concentrations in the mucosal cells. Effects of frequency of dose (P i 0.001), route through which the dose was administered ( P = 0.002), and the interaction between frequency and route ( P < 0.001) were significant. As indicated by ferritin concentration, multiple doses of the oral Fe supplement caused Fe loading of the cells while single-doses resulted in much lower femtin values. Synthesis of ferritin in the mucosal cells was affected by the route of administration depending on the frequency of the Fe dose. Oral Fe supplements produced more femtin when the doses were administered daily. In (Brittin & Raval, 1970 , 1971 ) who found that Fe-deficient animals retained the capacity to synthesize mucosal ferritin in response to small doses of oral Fe. To date, the role of mucosal ferritin in Fe absorption remains controversial. In this study we examined the extent to which any Fe remaining in the cells during oral treatment inhibits subsequent Fe absorption. Specifically, we evaluated the extent and nature of the blocking effect during the treatment of Fe deficiency in two ways: (1) by comparing oral v. i.p. Fe supplementation, and (2) by comparing daily supplements v. a single dose designed to match mucosal cell turnover. We found that oral supplementation was as effective as i.p. injection in improving the Fe status of the anaemic animals. An earlier study in humans also reported no significant difference in the haematological response of severely Fe-deficient patients to orally administered FeS04 and i.p. Fe-dextran complex (McCurdy, 1965) . Our finding suggests that the blocking effect in oral supplementation does not have a great impact on the recovery of anaemic animals. It also shows that the estimated 80% absorption that we used as a correction factor for oral v. i.p. administration is consistent with previous results in the literature (Pritchard, 1961) .
Intestinal absorption of a test dose, however, was higher in groups that received supplemental Fe by i.p. injection suggesting some kind of absorption block after exposure to oral Fe. Fe stores were equally repleted in the oral and i.p. groups, thus they cannot account for the higher absorption efficiency of the test dose in the i.p. groups. Nevertheless, as stated earlier, both oral and i.p. administrations resulted in an equal rate of recovery in terms of Fe status, i.e. Hb gain and liver Fe. The above-mentioned data suggest that differences in Fe absorption may exist when measured from a single labelled Fe test dose (Fe solution without food) or when estimated from values of Fe status.
When comparing daily supplements v. a single dose designed to match mucosal cell turnover we found that a single dose of 12mg was as effective in improving the Fe status of the anaemic animals as three daily doses of 4mg each, even when it is known that a greater proportion of Fe is generally absorbed with a smaller dose (Hahn et al. 1951) . Although the single oral dose of 4 mg of Fe was not sufficient to return Hb values to normal, it was more effective in improving the Fe status of the animals than three daily doses of 4 mg each as determined by HRE. The HRE of this group (4 mg oral once) was remarkably higher than that of three daily oral doses of 4 mg (30 v. 16 %) but this higher efficiency in Hb regeneration was not observed in the i.p. groups where a single dose of 3.2mg and three daily doses of 3.2mg resulted in HRE of 28 and 23 % respectively ( P > 0.05). These data are consistent with previous reports (Wright & Southon, 1990; Viteri et al. 1995) and suggest that administering intermittent Fe doses may be more effective than daily administration in correcting Fe deficiency anaemia. However, no significant difference was found in the absorption efficiency of a subsequent test dose within the orally supplemented groups.
The hypothesis that intestinal mucosal Fe concentration plays a role in Fe absorption cannot fully explain the higher absorption from the test dose observed in the i.p. groups. On the one hand, the group that received daily i.p. supplements had significantly less mucosal ferritin and absorbed significantly more Fe than did rats provided with oral supplements. This finding alone seems to suggest that the Fe levels of the mucosal cells, as determined by mucosal ferritin, may alter their absorptive capacity. On the other hand, the same finding was not evident in the other treatments. Ferritin concentrations in groups given single oral doses of Fe did not differ markedly from concentrations in rats given i.p. supplements (Table 4 ), yet the range of absorption of the oral groups was much lower than that of the i.p. ones.
Overall, our ferritin data correlated well with the Fe status as assessed by liver non-haem Fe of the animals ( r 0.461, P = 0.002). As stated earlier, there was no difference in the state of repletion between the oral and i.p. groups as indicated by Hb-Fe gain and liver Fe stores. This was also reflected in terms of mucosal fenitin for regimens 2 (4 mg oral once and 3.2 mg i.p. once) and 3 (1 2 mg oral once and 9.6 mg i.p. once). Groups in regimen 1 (daily 4 mg oral and daily 3.2 mg i.p.) and i.p. daily and once (9.6 mg) were the exception. For regimen 1, despite the equal repletion state between oral and i.p. groups, mucosal femtin was found in greater amounts in the oral than in the i.p. group. It is likely that body Fe stores in the i.p. group were not in equilibrium with the Fe content of intestinal mucosal cells due to our choice of a short study period (3 d). Indeed, we chose this brief supplementation period to test whether mucosal Fe was important in Fe absorption regardless of body Fe stores.
Fe can induce ferritin synthesis in a concentrationdependent manner (Drysdale & Shafritz, 1975) . However, mucosal ferritin was found in larger amounts in the daily group (4mg/d for 3d) compared with the single-dose group receiving the same quantity of total Fe (12 mg). This was probably due to the shedding of the cells exposed to supplemental Fe on day 1 at the end of their 2d life span. For the i.p. groups (3.2mg daily and 9.6mg once), it is interesting that, while they were equally repleted, more mucosal ferritin accumulated in the group given a single 9.6 mg dose than the other group. Indeed, the intermittent group (9.6mg once) received the injection 3 d before the measurement of ferritin in the cells but the daily group (3.2mg daily) received the last injection less than 24h before the tissues were collected. Since Wood et al. (1968) demonstrated that liver is the site of primary plasma clearance of the Fe-dextran complex and that this complex clears plasma with a t I , > of 2.5-3 d, it is likely that by the time our animals were killed only the Fe doses injected on day 1, and possibly those on day 2, have had the chance to reach the mucosal cells. This would explain the similar ferritin values found in groups 4 (3-2mg i.p. daily) and 5 (3.2mg i.p. once). It could also explain why the i.p. daily group, while equally repleted as the oral daily group, synthesized less mucosal ferritin than their oral counterpart. Another possibility is that Fe from the last 2d of i.p. injection in the daily group may not have been equally distributed in all epithelial cells. Conrad et al. (1964) found that when radio-Fe was administered parenterally, the cells at the base of the villi were labelled first followed by a 72 h lag before all cells were labelled. The mechanical vibration technique used to isolate mucosal cells in our study has been reported to yield 80-90% epithelial cells of which columnar 'tip cells' and rounded 'crypt cells' are found in approximately equal numbers (Levine & Weintraub, 1970 (Conrad & Crosby, 1963) . However, our data do not fully support this hypothesis since the single-dose groups (3.6 mg once and 9.6 mg once) had received the injection 72 h before the administration of the isotope yet their absorption values did not differ from the daily group which received the injection 2 4 h before dosing. Our results, as well as those from Schumann et al. (1990) , indicate that liver Fe stores have no means of neural or hormonal communication with the mucosal cells in adapting Fe absorption to the state of repletion at short notice.
We observed a significant positive correlation between Hb-Fe gain and liver stores in this experiment ( I 0.724, P < 0.001). It has been stated and accepted as fact that the sequence of events during oral treatment of Fe deficiency anaemia is normalization of the Hb value first, followed by restoration of storage Fe (Bothwell & Finch, 1962 
